APC sent a letter to the New Mexico Board of Pharmacy this week commenting on its proposed amendments that would align the state with USP (good), but would also require that pharmacists ensure all flavors are inert (yikes). read more →
The APC Board of Directors has voted to name Gina Besteman (previously vice president) the board chair-elect after the resignation of Michelle Moser from the position. Besteman will assume the chair in January 2025. read more →
Earlier this week APC received a letter from the FDA explaining the agency's concerns regarding dosing and patient usage of compounded semaglutide and tirzepatide. read more →
If you haven’t already, don’t forget to download and share the 2023-2024 edition of our Snapshot of Pharmacy Compounding in America — a slick guide to the most important information and numbers that reflect the practice of pharmacy compounding in the US.
It’s perfect for sharing with policymakers, media, prescribers, and anyone else who could benefit from a primer on the practice.
The snapshot was made possible by the generous support of APC corporate patrons Fagron, Medisca, and PCCA.
